tert-Butyl (3-bromo-5-methylbenzyl)carbamate

Catalog No. :
ACSFCU463
CAS No. :
1998726-82-1
Molecular Formula :
C13H18BrNO2
Molecular Weight :
300.20

IUPAC Name:tert-butyl (3-bromo-5-methylbenzyl)carbamate

tert-Butyl (3-bromo-5-methylbenzyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$172.00Login to see priceInquiryInquiry
250mg95%$292.00Login to see priceInquiryInquiry
1g95%$788.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-bromo-5-methylbenzyl)carbamate
IUPAC Nametert-butyl (3-bromo-5-methylbenzyl)carbamate
MDL No.MFCD30531038
Molecular FormulaC13H18BrNO2
Molecular Weight300.20
SMILESCC1=CC(Br)=CC(CNC(=O)OC(C)(C)C)=C1
InChI KeyXEAXPJVDUPDTGM-UHFFFAOYSA-N
SynonymTERT-BUTYL (3-BROMO-5-METHYLBENZYL)CARBAMATE;Carbamic acid, N-[(3-bromo-5-methylphenyl)methyl]-, 1,1-dimethylethyl ester;1,1-Dimethylethyl N-[(3-bromo-5-methylphenyl)methyl]carbamate
CAS No.1998726-82-1
PubChem CID122510348

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSFCU463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFYKX347 route compound structure diagram
    ACFYKX3471646570-05-9
  4. Then
  5. ACSFCU463 route product structure diagram
    ACSFCU4631998726-82-1
Inquiry

2. ACSFCU463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSFCU463 route product structure diagram
    ACSFCU4631998726-82-1
Inquiry

Comments (0)